To the central content area :::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

6461 Intech
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
LIN, CHIH-HUI WU, WEI- HSIU Steve Pi 02-77218877 3F., No.36, Ln. 358, Ruiguang Rd.,Neihu Dist., Taipei City 114, Taiwan 2018/03/28
Industry Main Business
Biotechnology and Medical Care Intech Biopharm Ltd, is a pharmaceutical company that develops, produces and markets specialized drugs focusing on the respiratory treatment categories. By owning strong RD team and the superior HFA MDI platforms with facilities at the high level as EMA and US FDA standard, we are not only supply high barrier generic drugs but also challenge 505b2 and new combination drug for obstructive airway diseases. In 2017, our new manufacturing site opened, which is a dedicated respiratory drug products manufacturing plant. This manufacturing site can offer 15 million MDI and 1.5million DPI products per year. Our mission is to provide Innovation, Quality, Professional and Care products and services to patients and customers.
Market Information ( 2024/06/17 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
223.043 28.00  27.30  27.90  0.60  210 .00 0 0
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
Normal N N N N N Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.